BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18253031)

  • 1. Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20.
    Mackinnon RN; Campbell LJ
    Cytogenet Genome Res; 2007; 119(3-4):211-20. PubMed ID: 18253031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion.
    Mackinnon RN; Selan C; Wall M; Baker E; Nandurkar H; Campbell LJ
    Genes Chromosomes Cancer; 2010 Nov; 49(11):998-1013. PubMed ID: 20645416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies.
    MacKinnon RN; Campbell LJ
    Cancer Genet Cytogenet; 2005 Dec; 163(2):176-9. PubMed ID: 16337864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB; Mallo M; Arenillas L; Salido M; Espinet B; Pedro C; Florensa L; Serrano S; Solé F
    Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unbalanced translocations of 20q in AML and MDS often involve interstitial rather than terminal deletions of 20q.
    MacKinnon RN; Duivenvoorden HM; Campbell LJ
    Cancer Genet; 2011 Mar; 204(3):153-61. PubMed ID: 21504715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes.
    MacKinnon RN; Patsouris C; Chudoba I; Campbell LJ
    Genes Chromosomes Cancer; 2007 Jan; 46(1):27-36. PubMed ID: 17048234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
    Li T; Xue Y; Wu Y; Pan J
    Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
    Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
    Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere.
    Andersen MK; Pedersen-Bjergaard J
    Leukemia; 2000 Jan; 14(1):105-11. PubMed ID: 10637484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dicentric Chromosome dic(20;22) Is a Recurrent Abnormality in Myelodysplastic Syndromes and Is a Product of Telomere Fusion.
    MacKinnon RN; Duivenvoorden HM; Campbell LJ; Wall M
    Cytogenet Genome Res; 2016; 150(3-4):262-272. PubMed ID: 28259884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
    Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
    Braun T; de Botton S; Taksin AL; Park S; Beyne-Rauzy O; Coiteux V; Sapena R; Lazareth A; Leroux G; Guenda K; Cassinat B; Fontenay M; Vey N; Guerci A; Dreyfus F; Bordessoule D; Stamatoullas A; Castaigne S; Terré C; Eclache V; Fenaux P; Adès L
    Leuk Res; 2011 Jul; 35(7):863-7. PubMed ID: 21396711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.